Metraipolis › archive › dc_30f2be249d1c

Neoantigens in cancer immunoediting: from mechanisms to personalized vaccines in breast cancer — Europe PMC PMID:41567982

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41567982
DOI
10.3389/fcell.2025.1733549
License (as archived)
solo-consultazione
Archived
2026-11-07T00:43:28.898Z
SHA-256 of the archived text
b270e435c1281101aff9834ff24647ff26fef4435ed11b7d52ee41a8d6ae4656
Stable URL of this page
https://metraipolis.com/documento/dc_30f2be249d1c

How to cite

Neoantigens in cancer immunoediting: from mechanisms to personalized vaccines in breast cancer — Europe PMC PMID:41567982 — Europe PMC (en), https://europepmc.org/article/MED/41567982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_30f2be249d1c (Metraipolis archive dc_30f2be249d1c, sha256 b270e435c1281101aff9834ff24647ff26fef4435ed11b7d52ee41a8d6ae4656)
BibTeX
@misc{dc30f2be249d1c,
  title = {Neoantigens in cancer immunoediting: from mechanisms to personalized vaccines in breast cancer — Europe PMC PMID:41567982},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41567982},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_30f2be249d1c; sha256 b270e435c1281101aff9834ff24647ff26fef4435ed11b7d52ee41a8d6ae4656},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41567982. Agents can read the archived copy with the MCP tool read_document.